Hudson Bay Capital Management
UTHR icon

Hudson Bay Capital Management’s United Therapeutics UTHR Stock Holding History

Hudson Bay Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-101,000
Closed -$32.2M – 1053
2024
Q2 		$32.2M Buy
+101,000
New +$26.7M 0.15% 94
2017
Q3 		– Sell
-113,600
Closed -$14.7M – 537
2017
Q2 		$14.7M Sell
113,600
-5,200
-4% -$649K 0.3% 78
2017
Q1 		$16.1M Buy
+118,800
New +$18M 0.22% 93

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Hudson Bay Capital Management's UTHR Position: Q1 2026 in Review

Hudson Bay Capital Management opened a new position in United Therapeutics (UTHR) in Q1 2026: 20,918 shares worth $12.4M. The stake represents 0.04% of the portfolio and ranks #273 among its holdings. This is a return to the name: Hudson Bay Capital Management previously reported a position in UTHR as recently as Q3 2025.

Hudson Bay Capital Management first reported a position in UTHR in Q1 2017 and has held it in 15 quarters since. The position peaked at $24.8M in Q4 2024. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Hudson Bay Capital Management held 20,918 shares of United Therapeutics worth $12.4M as of Q1 2026.
  • United Therapeutics was a new Hudson Bay Capital Management position in Q1 2026.
  • United Therapeutics made up 0.04% of Hudson Bay Capital Management's portfolio in Q1 2026, its #273 holding.
  • Hudson Bay Capital Management first reported a position in United Therapeutics in Q1 2017 and has held it in 15 quarters since.
  • Hudson Bay Capital Management's United Therapeutics position peaked at $24.8M in Q4 2024.
  • 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.